OverviewChartNewsTraderScreen

UniCredit Call 640 LLY 17.06.2026/  DE000HD5AJE9  /

EUWAX
31/05/2024  20:34:49 Chg.-0.44 Bid22:00:42 Ask22:00:42 Underlying Strike price Expiration date Option type
25.10EUR -1.72% -
Bid Size: -		 -
Ask Size: -		 ELI LILLY 640.00 - 17/06/2026 Call
GlobeNewswire 30/05 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire 30/05 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 24/05 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
TeleTrader 24/05 Eli Lilly to reveal $5.3B production boost
GlobeNewswire 23/05 Gov. Holcomb elevates Indiana to the world’s stage at Global Economic Summit
GlobeNewswire 23/05 Gov. Holcomb elevates Indiana to the world’s stage at Global Economic Summit
GlobeNewswire 23/05 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
TeleTrader 21/05 Eli Lilly's diabetes drug receives authorization in China
GlobeNewswire 16/05 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire 16/05 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire 16/05 HEPHAISTOS secures €10.3 M to reach the clinical stage
GlobeNewswire 15/05 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
GlobeNewswire 13/05 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire 09/05 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 09/05 Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...
GlobeNewswire 09/05 ProQR Announces First Quarter 2024 Operating and Financial Results
GlobeNewswire 08/05 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire 08/05 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire 08/05 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
GlobeNewswire 08/05 ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting...
GlobeNewswire 08/05 Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
GlobeNewswire 03/05 BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and U...
GlobeNewswire 01/05 H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors
GlobeNewswire 30/04 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
TeleTrader 30/04 Eli Lilly's Q1 revenue surges 26% to $8.8B